Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

To Measure is to Know

Gretchen Henkel  |  Issue: October 2007  |  October 1, 2007

Interestingly, the Dutch population presented certain limitations that the investigators turned to their advantage. From James F. Fries, MD, professor of medicine at Stanford University School of Medicine (Calif.), and others working with longitudinal patient databases, Dr. van Riel learned that it is important to collect data, to quantify the amount of response and the amount of disease activity. “But, I also learned that it was not possible to do that [on the same large scale] in the Netherlands,” he says, “because we are a very small country and we have fewer patients.”

His solution? “It’s better to do the same kind of research (collecting data and following patients long-term) but to do it more intensely,” says Dr. van Riel. A national characteristic which facilitated this idea, he explains, is that patients in the Netherlands do not move around as much as their counterparts in the United States. “They will continue to visit you [the rheumatologist] for many, many years. We have patients who have been in our study for 20 to 25 years and have not moved,” he says. “So the advantage is that you can do more precise assessments and you can get a lot more information than if you combine patients in your study from many different centers.” The latter approach, notes Dr. van Riel, can introduce “a lot of noise and variation” into statistical analyses, because patients at different centers will be assessed by different teams of physicians and nurses.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

It Takes a Team

Another influence on Dr. van Riel’s thinking about assessment was Howard A. Bird, MD, professor of pharmacological rheumatology at Leeds University in the U.K., who wrote a book about multidisciplinary care of rheumatoid arthritis patients. Dr. van Riel and his colleagues adopted Bird’s approach, which relied on utilization of a nurse-specialist for patient education and clinical assessments, easing the burden on rheumatologists to conduct assessments for their studies. This made collection of data easier, and also motivated patients, says Dr. van Riel, because they benefited from the counseling that nurses delivered.

The approach was not uniformly embraced by his colleagues, however. In the beginning, not all rheumatologists liked the multidisciplinary approach. “They felt, ‘I am responsible for my patients and they should discuss all their problems with me,’” he notes wryly.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

It took some time for the approach to be accepted. Dr. van der Heijde notes that the approach “was indeed new at that time. More and more centers are now doing this, but at that time there were very few.” Dr. Landewé agrees: “Initiating that early RA cohort with the help of research nurses was very innovative and unprecedented in those days.”

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Profiles Tagged with:Diagnostic CriteriaDisease Activity Score (DAS)MetricsRheumatoid Arthritis (RA)

Related Articles

    Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances

    May 8, 2012

    Dr. van der Heijde learned early in her career that serendipity often plays a role in clinical research and treatment advances.

    Target Remission

    March 1, 2007

    Strategies to identify and track remission in your RA patients

    The Many Facets of COVID-19: Experts Address Basic & Clinical Research Concepts in the COVID-19 Era

    November 23, 2021

    New concepts in autoimmunity & immunology are being discovered daily in research being conducted to understand the SARS-CoV-2 virus and its implications for rheumatology & all fields of medicine. Here are some insights shared by experts during day 1 of the Basic and Clinical Research Conference.

    European Beacon for Rheumatology

    January 1, 2008

    Josef S. Smolen, MD, led the way for outcomes measures and a scientifically based training program

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences